Which ARK Innovation ETF is best? Let’s perform an Ark ETF review.
Today, I will introduce to you the five actively managed ETFs in ARK INNOVATION. Let’s take a look at which types of companies they have invested in so that you can choose the industry you like to invest in.
ARK INNOVATION was founded by Catherine Wood. This investment company is a revolutionary and innovative company that specializes in investment. Their company currently manages seven different types of ETFs, five of which are actively managed ETFs, and the other two One is an exponential passive ETF,
Simply put, the biggest difference between these two ETFs is that for actively managed ETFs, they will frequently trade the company stocks in the fund, so the proportion of the company he holds will always change, while the index-type ETF is as they think. After purchasing the company, you will not be able to move it again. It is very similar to S&P500 or QQQ, except that the holding company is different. Then let's take a brief look at these five actively managed ETFs. What types of startup companies are there?
The first one is ARKK, which we talked about before. It is a company that specializes in investing in revolutionary innovations. It includes the widest variety of companies, such as companies related to genetic technology, full automation, Internet of Things, or financial technology, etc. The above is the sum of the other four ETFs,
What about the next ETF, ARKQ, which is an ETF that specializes in investment in robot automation-related companies, including autonomous driving, automated robots, 3D printing, energy storage technology, space exploration, and other related companies.
The next ETF is ARKW, which is a dedicated investment, next-generation network-related companies, such as cloud computing, network security, e-commerce, big data analysis, artificial intelligence, Internet of Things, social platforms, and blockchain And other related companies,
The next ETF is ARKG, which focuses on investing in genetic technology-related companies, such as gene-editing technology, dart target therapy, bioinformatics, molecular diagnostics, stem cells, and agricultural biology-related companies.
The last one is that he invests in ETF and ARKF of financial technology stock-related companies, including trading platforms, blockchains, crowdfunding platforms, and other related companies.
Let's take a look at the first few companies that each ETF invests in. Now let's look at the basic information of each ETF. The fee for each ETF is mostly 0.75%, except for ARKW which is a little more expensive. %, I don’t know why. In terms of fund size, ARKK currently manages the most money. As of June 30 this year, it managed US$4.8 billion.
And ARKF is the smallest, only about 221 million U.S. dollars. In terms of performance, their rate of return is far better than S&P500. The performance in one year is ARKW's best, as high as 62.86%, in terms of five-year performance ARKW is also the best, with as high as 34.24%. Looking carefully, each ETF usually holds 30 to 55 companies, and because they are actively managed, how many companies they hold will be different in each period.
Then let's compare the companies held by each ETF. If we compare their four main ETFs with the companies held on July 24, we will find that the types of companies in ARKK include all the new ones. In the startup industry, the companies they hold are scattered in other ETFs and all have shared, and although the remaining ETFs have duplicates, they all have a lot of independent holding companies, so you can come to the conclusion that ARKK holds. Major companies in each future industry and other ETFs will invest more in other companies related to their industries according to their industry themes.
Then, let’s briefly introduce them. At present, each ETF holds the top ten companies with the highest proportion.
Let’s start with ARKK
The first company to be introduced is this Crispr, Therapeutic, U.S. stock code CRSP. It is a company that uses a very new gene-editing technology CRISPR to treat a variety of genetic diseases. There are currently four products in the clinical stage. , There is no product on the market, we have the opportunity to talk about this company in detail,
Then there is ROKU, the U.S. stock code ROKU. What they do is to replace and combine traditional cable TV and new online media, so that users can save cable TV fees and use their platform to see it on TV. For all the programs that I want to watch, the turnover has grown in the past few years. At present, there are nearly 40 million users in the United States alone. The growth is amazing, but there is still no way to make a profit at this stage.
The next one is Protolabs, the U.S. stock code is PRLB. This is a product that uses 3D printing and other methods to automate and fast process customers. The operating conditions are quite good, and they can be stable and profitable, and the problem will arise. The reason is that last year's turnover growth has slowed down, so the stock price is not too expensive at present. I want to buy a few shares and put them there, but I may have to go before that. , Learn about the 3D printing industry and know about his competitors,
The next one is Zillow, the U.S. stock code is Z. This is a store that allows people to inquire about any house-related information on the Internet, including house sales, rentals, etc., I believe their long-term goal is to replace houses Intermediaries, after all, housing agencies in the United States have a very high commission. The same is true for companies that are currently unable to make a profit. However, as long as this useful online platform company grows larger, I believe that there will be opportunities for profit in the future.
The last one is LendingTree, the U.S. stock code TREE. It can be said to be Booking.com in the borrowing industry. It allows the public to find the most suitable or cost-effective borrowing unit on it. It is currently stable and profitable. I feel that these are all considered. A new company, I don’t know if you like it or not,
Then let's take a look at the next ETF, ARKQ
The top ten companies currently held, let's take a look at this Xilinx, the U.S. stock code XLNX, Xilinx, which specializes in programmable chips (FPGA), 5G mobile network operators, and Nokia's 5G Mobile base stations use programmable chips (FPGA). This is a very flexible chip. As long as it is equipped with different software, it can have different applications. Sometimes the performance can even exceed GPU and CPU. Their profitability is also It is quite good, but because the growth of turnover is slowing down, it is expected to be lower this year, so the stock price is not high. I don't know if everyone will be interested.
Then let's look at the next company, Materialize, the U.S. stock code is MTLS. This is a company in Belgium that does 3D printing services, including software and product services. Their role is to help their customers. The 3D printing method produces things. It is a relatively small company. Its growth has slowed down last year, but it can still stabilize a small amount of profit.
The next company to look at is Stratasys, the U.S. stock code is SSYS. It is a company located in Israel. It mainly helps customers to use 3D printing technology to produce the products they need. His turnover grew negatively last year. I have been unable to make a profit. I don’t know what is the difference between the two 3D printing companies as we just talked about.
Let's retake a look, this exciting company, AeroVironment, the U.S. stock code is AVAV. It specializes in unmanned fighter aircraft, missiles, pseudo satellites, etc., and its turnover is growing steadily, and it can make stable profits. But hope These things are made to deal with bad aliens,
The next company they hold is Splunk, the U.S. stock code is SPLK. The main business is to help customers, collect and analyze all kinds of data, whether it is from servers, application services, cloud, desktop, mobile, etc., it can be effectively integrated Data is used to improve the efficiency of customer service. The turnover has grown by more than 30% every year. There is no way to make a profit at present.
Then let’s look at the next company, Teradyne, the U.S. stock code is TER. He is a machine that specializes in semiconductor wafer packaging and testing. As far as I know, TSMC’s testing machines seem to be at least part of it. Their turnover has been stable in the past two years, but not growing rapidly, but at least they can be stable and profitable.
The last company is JD.com. The U.S. stock code is JD. It is an online retailer, such as a department store on the Internet. It mainly sells goods on the Internet to general users, earns product prices, and their turnover. Both have stable growth, and profitability is sometimes good and sometimes bad.
Next is ARKW which has grown the most
We have talked about most of the companies in front of him, and only three companies have not talked about them.
The first one is Snap, the U.S. stock code is SNAP. He said that he is a camera company, but in fact, his most famous is Snapchat, which is also considered a social software. His turnover last year grew by more than 50%, but it still Not profitable,
Next is Tencent. The U.S. stock code is TCEHY. He can be regarded as the largest Internet company in China. Everyone uses QQ and WeChat. He is also a company that has been growing and stable and profitable.
The other is Amazon. The U.S. stock code is AMZN. It can be regarded as the most important online e-commerce platform in the United States. It has done a lot of miscellaneous things, and its turnover has grown steadily, and it can also make stable profits. His stock price is also flying. The sky is up, take a closer look at the ten companies of ARKW, the stock prices have risen to the sky recently, no wonder his rate of return is super high,
Then we will introduce the top ten companies held by ARKG
Because he is mainly bio-related, it is very different from the previous ones. Let's take a look at which companies he holds shares.
The first is Arcturus, Therapeutics, and the U.S. stock code is ARCT. This is a disease treatment and vaccine company. Using their unique technology, RNA molecules can be delivered into cells. There are currently two products in clinical trials, one of which is The COVID-19 vaccine, I don't know if it will succeed,
Let's take a look at the next company, Compugen, under the U.S. stock code CGEN. This is a company specializing in the development of cancer immunotherapy and autoimmune therapy. At present, most of its products are in first-level clinical trials, and there are no products on the market. Up,
Then let's retake a look, the next company, Intellia, Therapeutics, US stock code NTLA, is also a very new gene-editing technology, CRISPR, to treat cancer and immune system diseases, currently, only one drug is being used in Primary clinical trials, I will talk about my views on CRISPR later,
The next company they hold is Iovance, Biotherapeutics, and the U.S. stock code is IOVA. This company specializes in using lymphocyte technology to treat cancer. It uses and extracts the patient's tumor invading lymphocytes (Tumor, Infiltrating, lymphocytes). This type of cell will kill cancer cells, it is possible to produce a large number of such cells to treat cancer. They currently have a drug that enters the third phase of clinical trials. This is the most interesting one among the several cancer drug companies I have seen so far. I will study it if I have the opportunity.
The next company is CareDx, the U.S. stock code is CDNA. It specializes in helping patients and doctors of organ transplantation to monitor the results of transplantation and the patient's physical response. The current products include tests for kidney and heart transplantation, and their turnover It has been growing in the past few years, and it is still unable to make money, but it feels that it is also a company with great growth in the future.
The next company is Twist, Bioscience, and the U.S. stock code is TWST. They use a unique platform to generate a large number of desired DNA sequences. This year, they have also done a virus test panel in the fight against COVID-19. The turnover has grown by more than 100% in recent years, and the gross profit has also turned positive last year. However, the overall operating expenses are still quite high, so they are still in a state of loss.
The last company is Editas, Medicine, and the U.S. stock code is EDIT. It is also a company that specializes in gene-editing technology for the treatment of various gene diseases. Currently, there is a product in clinical trials. It seems that ARKG has invested a lot, A company that uses CRISPR to do gene editing, here I will talk more about my views, I personally still have reservations about this technology, because in fact, its accuracy rate is not very high, and I usually do it on mice. The experiment is okay. It is a bit of a problem to hit the human body. You don't want to edit another good gene into a bad one to cure one gene. Besides, I think it is possible to do gene knockout. It is necessary to successfully edit only one gene. , It is still unlikely at the moment,
Let's take a look at the last ETF, ARKF
It is an ETF that specializes in investing in innovative financial technology companies. Let's take a look at the companies he holds.
The first is Square, interested friends can go and see
The second company Mercado, Libre, is located in Argentina, and the U.S. stock code is MELI. It is the largest e-commerce platform in Latin America. Its turnover is growing steadily, but there is still no way to make stable profits.
Then let's look at the next one, which is Apple. The U.S. stock code is AAPL. It is another company that does not need to be introduced. The reason why he is included in the ETF of fintech stocks is mainly because of him. Apple, Pay, it is currently estimated that in 2023, the turnover of Apple and Pay alone can reach 4 billion U.S. dollars, which is quite amazing.
The next company is PayPal. The U.S. stock code is PYPL. This is also a well-known online third-party payment service provider. His turnover and profit have always been growing steadily. Pinterest, the U.S. stock code PINS, and the Chinese name are Pinqu. It is an online platform that allows users to create or search for creative images. It is also a company that has grown in revenue but is not profitable.
The last thing I want to introduce is this Chinese Pinduoduo, the U.S. stock code PDD, is also an e-commerce platform. It allows everyone to buy in groups and buy goods at a lower price. It combines the concepts of shopping and social sharing, and turnover. There is rapid growth, but the same is not currently profitable,
Ok, ARKF's company has also been introduced. After reading it, which ETF do you prefer?
Investing in ARKK means that everything has a little edge, and other ETFs will be more concentrated. In the same type of company, I currently don't buy it, but if I want to choose, I might choose ARKK and ARKQ. Because of the biotech company, I want to pick it myself, and Intel said when it recently held a financial report meeting that they estimated that the current cloud computing Our product demand has reached a peak, so it is expected that the demand for their products will be reduced in the future. In this way, I will not buy ARKW that focuses on cloud computing companies. I don't know which one you will want to buy. Today is mainly I want to introduce these ETFs, I conducted an Ark ETF review，and by the way, the companies they hold, so the introduction to the company is very superficial. If you have optimism about the company, please leave a message below.
Comments
Post a Comment